ATE201871T1 - Durch einen heterocyclischen ring substituierte imidazoline als alpha-2 antagonisten - Google Patents
Durch einen heterocyclischen ring substituierte imidazoline als alpha-2 antagonistenInfo
- Publication number
- ATE201871T1 ATE201871T1 AT98401919T AT98401919T ATE201871T1 AT E201871 T1 ATE201871 T1 AT E201871T1 AT 98401919 T AT98401919 T AT 98401919T AT 98401919 T AT98401919 T AT 98401919T AT E201871 T1 ATE201871 T1 AT E201871T1
- Authority
- AT
- Austria
- Prior art keywords
- optionally substituted
- alkyl
- substituted
- cycloalkyl
- alkoxy
- Prior art date
Links
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical group C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- -1 Heterocyclic imidazoline derivatives Chemical class 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004385 trihaloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9709709A FR2766824B1 (fr) | 1997-07-30 | 1997-07-30 | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201871T1 true ATE201871T1 (de) | 2001-06-15 |
Family
ID=9509815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98401919T ATE201871T1 (de) | 1997-07-30 | 1998-07-28 | Durch einen heterocyclischen ring substituierte imidazoline als alpha-2 antagonisten |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6057317A (de) |
| EP (1) | EP0894796B1 (de) |
| JP (1) | JPH1192476A (de) |
| CN (1) | CN1090631C (de) |
| AT (1) | ATE201871T1 (de) |
| AU (1) | AU736460B2 (de) |
| BR (1) | BR9802803A (de) |
| CA (1) | CA2244435A1 (de) |
| DE (1) | DE69800883T2 (de) |
| DK (1) | DK0894796T3 (de) |
| ES (1) | ES2159921T3 (de) |
| FR (1) | FR2766824B1 (de) |
| GR (1) | GR3036474T3 (de) |
| HU (1) | HUP9801713A1 (de) |
| NO (1) | NO311256B1 (de) |
| NZ (1) | NZ331154A (de) |
| PL (1) | PL327747A1 (de) |
| PT (1) | PT894796E (de) |
| ZA (1) | ZA986815B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2799757B1 (fr) * | 1999-10-15 | 2001-12-14 | Adir | Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| ZA200601423B (en) * | 2003-09-01 | 2007-04-25 | Ono Pharmaceutical Co | Condensed ring compound and use thereof |
| CA2537355C (en) * | 2003-09-01 | 2012-10-09 | Ono Pharmaceutical Co., Ltd. | Condensed ring compound and use thereof |
| EP1985297A1 (de) * | 2006-01-27 | 2008-10-29 | Japan Tobacco, Inc. | Karbonsäureverbindung und ihre verwendung |
| US20070197512A1 (en) * | 2006-01-27 | 2007-08-23 | Japan Tobacco Inc. | Carboxylic Acid Compounds and Use Thereof |
| TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
| JP5257490B2 (ja) | 2010-06-21 | 2013-08-07 | 小野薬品工業株式会社 | ４，４’−［４−フルオロ−７−（｛４−［４−（３−フルオロ−２−メチルフェニル）ブトキシ］フェニル｝エチニル）−２−メチル−１ｈ−インドール−１，３−ジイル］ジブタン酸、４，４’−［２−メチル−７−（｛４−［４−（ペンタフルオロフェニル）ブトキシ］フェニル｝エチニル）−１ｈ−インドール−１，３−ジイル］ジブタン酸および４，４’−［４−フルオロ−２−メチル−７−（｛４−［４−（２，３，４，６−テトラフルオロフェニル）ブトキシ］フェニル｝エチニル）−１ｈ−インドール−１，３−ジイル］ジブタン酸の新規結晶形 |
| US9216998B2 (en) * | 2012-02-15 | 2015-12-22 | Janssen Pharmaceutica Nv | Tricyclic indole derivatives useful endothelial lipase inhibitors |
| RU2687979C1 (ru) * | 2018-03-19 | 2019-05-17 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ коррекции стрептозотоцин-индуцированного сахарного диабета у крыс с использованием лекарственного средства на основе амида гетероциклических кислот |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199469A (en) * | 1981-01-30 | 1984-03-16 | Reckitt & Colmann Prod Ltd | Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions |
| US4436914A (en) * | 1981-08-03 | 1984-03-13 | Kluge Arthur F | Benzodioxane-imidazoline compounds as antihypertensives |
| NZ203680A (en) * | 1982-04-17 | 1985-08-16 | Reckitt & Colmann Prod Ltd | Imidazolines and pharmaceutical compositions |
-
1997
- 1997-07-30 FR FR9709709A patent/FR2766824B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-20 US US09/119,423 patent/US6057317A/en not_active Expired - Fee Related
- 1998-07-28 DE DE69800883T patent/DE69800883T2/de not_active Expired - Fee Related
- 1998-07-28 PT PT98401919T patent/PT894796E/pt unknown
- 1998-07-28 AT AT98401919T patent/ATE201871T1/de not_active IP Right Cessation
- 1998-07-28 DK DK98401919T patent/DK0894796T3/da active
- 1998-07-28 ES ES98401919T patent/ES2159921T3/es not_active Expired - Lifetime
- 1998-07-28 EP EP98401919A patent/EP0894796B1/de not_active Expired - Lifetime
- 1998-07-28 NO NO19983478A patent/NO311256B1/no not_active IP Right Cessation
- 1998-07-29 CN CN98116645A patent/CN1090631C/zh not_active Expired - Fee Related
- 1998-07-29 NZ NZ331154A patent/NZ331154A/xx unknown
- 1998-07-29 HU HU9801713A patent/HUP9801713A1/hu unknown
- 1998-07-29 JP JP10213603A patent/JPH1192476A/ja active Pending
- 1998-07-29 PL PL98327747A patent/PL327747A1/xx unknown
- 1998-07-29 CA CA002244435A patent/CA2244435A1/fr not_active Abandoned
- 1998-07-30 BR BR9802803A patent/BR9802803A/pt not_active IP Right Cessation
- 1998-07-30 ZA ZA986815A patent/ZA986815B/xx unknown
- 1998-07-30 AU AU78609/98A patent/AU736460B2/en not_active Ceased
-
2001
- 2001-08-30 GR GR20010401333T patent/GR3036474T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6057317A (en) | 2000-05-02 |
| HUP9801713A1 (hu) | 1999-12-28 |
| HU9801713D0 (en) | 1998-09-28 |
| ES2159921T3 (es) | 2001-10-16 |
| AU736460B2 (en) | 2001-07-26 |
| PT894796E (pt) | 2001-09-28 |
| FR2766824B1 (fr) | 1999-09-10 |
| FR2766824A1 (fr) | 1999-02-05 |
| CN1090631C (zh) | 2002-09-11 |
| EP0894796B1 (de) | 2001-06-06 |
| BR9802803A (pt) | 2000-03-21 |
| AU7860998A (en) | 1999-02-11 |
| CN1206712A (zh) | 1999-02-03 |
| NO311256B1 (no) | 2001-11-05 |
| ZA986815B (en) | 1999-02-02 |
| EP0894796A1 (de) | 1999-02-03 |
| DK0894796T3 (da) | 2001-09-03 |
| GR3036474T3 (en) | 2001-11-30 |
| HK1017685A1 (en) | 1999-11-26 |
| DE69800883T2 (de) | 2002-03-28 |
| NO983478L (no) | 1999-02-01 |
| NO983478D0 (no) | 1998-07-28 |
| CA2244435A1 (fr) | 1999-01-30 |
| NZ331154A (en) | 1999-05-28 |
| DE69800883D1 (de) | 2001-07-12 |
| PL327747A1 (en) | 1999-02-01 |
| JPH1192476A (ja) | 1999-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3766198D1 (de) | Bizyklische aromatische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| LTIP846A (en) | N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran)carboxamide derivatives,processes for the preparation thereof and pharmaceutical compositions | |
| MY117557A (en) | 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives | |
| DK0546358T3 (da) | Farmaceutiske præparater med angiotensin-II-antagonistisk aktivitet | |
| ATE188472T1 (de) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
| ATE201871T1 (de) | Durch einen heterocyclischen ring substituierte imidazoline als alpha-2 antagonisten | |
| ATE164846T1 (de) | Neue siliciumhaltige salicylsäurederivate mit abschuppenden eigenschaften | |
| ATE144253T1 (de) | Methanoanthracene als dopaminantagonisten | |
| PT74261A (pt) | Neue carbonsaeureamide ihre herstellung und ihre verwendung als arzneimittel | |
| ATE61348T1 (de) | Polyzyklische aromatische verbindungen, verfahren zu deren herstellung, deren verwendung in menschlicher und tierischer medizin und in der kosmetik. | |
| AR247397A1 (es) | Compuestos de 1-oxa-3-oxo-4,8-diaza-espiro ¡4,5¿ decano. | |
| ATE122669T1 (de) | Zearalanol-derivate mit anabolytischer wirkung. | |
| DE50008187D1 (de) | Salze von Thrombininhibitoren | |
| DE3684367D1 (de) | Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte. | |
| ATE293950T1 (de) | Kosmetische aufhellung mit einem hydroxyphenyloxim-derivat | |
| AR247737A1 (es) | Un procedimiento para la fabricacion de compuestos. | |
| ES327297A1 (es) | Procedimiento para la obtencion de compuestos derivados de la quinazolina. | |
| RO85061B (ro) | Compozitie erbicida sinergetica | |
| NO980842D0 (no) | Nye benzensulfonylaminforbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske sammensetninger inneholdende slike | |
| AR037963A1 (es) | Piperidin-2,6-diona sustituida con heterociclo en la posicion 3, procedimiento para prepararla, medicamento que la contiene y su uso para preparar este ultimo | |
| GB1120310A (en) | Substituted naphthotriazines | |
| ZA9711708B (en) | Ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| CS262989A2 (en) | Method of new substituted 2,4-diamino-5-cyanopyrimidines production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |